InvestorsHub Logo
Followers 32
Posts 1400
Boards Moderated 0
Alias Born 06/18/2011

Re: None

Saturday, 11/21/2020 10:27:33 PM

Saturday, November 21, 2020 10:27:33 PM

Post# of 198829
Forgive me if this has been covered, but trying to find out what we actually own. This article goes way back and states that

“ BTG, the global technology commercialisation company, announced today that it has acquired an important new human HIV antibody technology from researchers at BioClonetics. The antibody, identified as Clone 3, represents only the fifth human antibody worldwide with known anti-HIV potential. It has been demonstrated in in vitro tests to neutralise several clinical/primary strains of HIV virus.”

https://www.newmaterials.com/News_Detail_Biological_compound_could_provide_basis_for_broadspectrum_hiv_treatment_8428.asp